UTILISATION D'UN COMPOSÉ DE CARBAMATE POUR ATTÉNUER OU TRAITER DES TROUBLES DU DÉVELOPPEMENT COMPRENANT LE SYNDROME DU X FRAGILE, LE SYNDROME D'ANGELMAN OU LE SYNDROME DE RETT
The present invention relates to a use of a carbamate compound represented by chemical formula 1, or a pharmaceutically acceptable salt, a solvate or a hydrate thereof for reducing or treating developmental disorders including fragile X syndrome, Angelman syndrome or Rett syndrome.